THERAPY AND MANAGEMENT OF PAROXYSMAL PULMONARY EDEMA.
D002199:Capillary Permeability; D002318:Cardiovascular Diseases; D002493:Central Nervous System Diseases; D004071:Digitalis Glycosides; D005730:Ganglionic Blockers; D005767:Gastrointestinal Diseases; D006801:Humans; D006931:Hyperbaric Oxygenation; D006993:Hypnotics and Sedatives; D007674:Kidney Diseases; D008168:Lung; D009020:Morphine; D009369:Neoplasms; D010102:Oxygen Inhalation Therapy; D010276:Parasympatholytics; D011041:Poisoning; D011175:Positive-Pressure Respiration; D011654:Pulmonary Edema; D012140:Respiratory Tract Diseases; D013565:Sympatholytics; D014665:Vasodilator Agents
D004071:Digitalis Glycosides; D005730:Ganglionic Blockers; D006993:Hypnotics and Sedatives; D010276:Parasympatholytics; D013565:Sympatholytics; D014665:Vasodilator Agents; D009020:Morphine
CAPILLARY PERMEABILITY; CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM DISEASES; DIGITALIS GLYCOSIDES; GANGLIONIC BLOCKADERS; GASTROINTESTINAL DISEASES; HYPERBARIC OXYGENATION; HYPNOTICS AND SEDATIVES; KIDNEY DISEASES; MORPHINE; NEOPLASMS; OXYGEN INHALATION THERAPY; PARASYMPATHOLYTICS; POISONING; POSITIVE-PRESSURE RESPIRATION; PULMONARY EDEMA; RESPIRATORY TRACT DISEASES; REVIEW; SYMPATHOLYTICS; VASODILATOR AGENTS